Next Article in Journal
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
Next Article in Special Issue
Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing
Previous Article in Journal
D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective
Previous Article in Special Issue
Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
 
 
Article

Article Versions Notes

Antibiotics 2021, 10(6), 649; https://doi.org/10.3390/antibiotics10060649
Action Date Notes Link
article pdf uploaded. 28 May 2021 18:27 CEST Version of Record https://www.mdpi.com/2079-6382/10/6/649/pdf-vor
article xml file uploaded 30 May 2021 17:13 CEST Original file -
article xml uploaded. 30 May 2021 17:13 CEST Update -
article pdf uploaded. 30 May 2021 17:13 CEST Updated version of record https://www.mdpi.com/2079-6382/10/6/649/pdf-vor
article html file updated 30 May 2021 17:14 CEST Original file -
Correction published 9 October 2021 00:00 CEST Correction https://www.mdpi.com/2079-6382/10/10/1230
article pdf uploaded. 9 October 2021 11:54 CEST Updated version of record https://www.mdpi.com/2079-6382/10/6/649/pdf
article xml uploaded. 9 October 2021 11:54 CEST Update https://www.mdpi.com/2079-6382/10/6/649/xml
article html file updated 9 October 2021 11:56 CEST Update -
article html file updated 26 July 2022 21:54 CEST Update https://www.mdpi.com/2079-6382/10/6/649/html
Back to TopTop